Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/1088118]Researchers: Dr Emily Blyth (Principal investigator)
Brief description Acute myeloid leukaemia (AML) is the most common acute leukaemia in adults. Patients with high-risk AML have a 2-year survival of less than 20%. Blood or bone marrow transplant from a healthy donor is often the only chance of cure but the leukaemia frequently returns. We will perform a clinical trial giving leukaemia fighting immune cells from the transplant donor to patients with high risk AML to prevent relapse after transplant.
Funding Amount $AUD 404,081.60
Funding Scheme Project Grants
Notes New Investigator Grant
- nhmrc : 1088118
- PURL : https://purl.org/au-research/grants/nhmrc/1088118
